APA (7th ed.) Citation

JS, J., BE, D., V, G., K, P., FO, A., F, Z., . . . Y, W. (2021). Clinical Characteristics and Outcomes of Oral Mucositis Associated With Immune Checkpoint Inhibitors in Patients With Cancer. Journal of the National Comprehensive Cancer Network : JNCCN, 19(12), 1415. https://doi.org/10.6004/jnccn.2020.7697

Chicago Style (17th ed.) Citation

JS, Jacob, et al. "Clinical Characteristics and Outcomes of Oral Mucositis Associated With Immune Checkpoint Inhibitors in Patients With Cancer." Journal of the National Comprehensive Cancer Network : JNCCN 19, no. 12 (2021): 1415. https://doi.org/10.6004/jnccn.2020.7697.

MLA (9th ed.) Citation

JS, Jacob, et al. "Clinical Characteristics and Outcomes of Oral Mucositis Associated With Immune Checkpoint Inhibitors in Patients With Cancer." Journal of the National Comprehensive Cancer Network : JNCCN, vol. 19, no. 12, 2021, p. 1415, https://doi.org/10.6004/jnccn.2020.7697.